CHRISTUS Santa Rosa Hospital in New Braunfels is making a significant impact on heart health in the community with its Transcatheter Aortic Valve Replacement program.

J&J inherited the Javelin catheter as part of its $13.1bn acquisition of Shockwave Medical, which completed in June 2024.

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.

The expected outcome is successful treatment of the stenotic vessel; however, treatment may not totally correct the problem. Careful monitoring of blood pressure for hypertension becomes a long ...

Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in ...

Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling <a target=_blank ...

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

WASHINGTON--Cardiawave SA, developer of the groundbreaking Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for the ...

Cardiawave Completes 12-Month Follow-up for Valvosoft Pivotal Study; Publication of One-Year Results Expected in Early 2025 Cardiawave SA, developer of the groundbreaking Valvosoft Non-Invasive Ultras ...